VISCHER AG has advised Oculis. Oculis Holding AG has entered into an asset purchase agreement with Accure Therapeutics, S.L., to acquire all worldwide development and commercial...
Oculis Acquires Global Rights to Privosegtor and ACT-02 from Accure Therapeutics
Proteomedix AG Licenses Manufacturing IP for Cancer Diagnostic to Immunovia AB
VISCHER has advised Proteomedix AG on its licensing agreement with Immunovia AB. Proteomedix AG, a Swiss biotech subsidiary of Onconetix, Inc., has entered into a licensing...
AutoScout24 Integrates C2B Auction Platform from CARAUKTION
VISCHER has advised CARAUKTION. AutoScout24 has completed the acquisition of the consumer-to-business (C2B) segment previously developed in partnership with CARAUKTION, including the C2B auction platform. Effective...
Medartis Acquires Full Ownership of KeriMedical
VISCHER has advised Medartis. McDermott has advised KeriMedical. Medartis, a Basel-based orthopedic company listed on the SIX Swiss Exchange, has acquired the remaining 53% stake in...
Aktiia Raises USD 42 Million in Series B to Support Global Expansion
VISCHER has advised Earlybird Health, Wellington Partners, Kfund, and naturalX Health Ventures. Aktiia, a company specializing in blood pressure intelligence technology, has successfully raised USD 42...